News
Patient treated at Clinica la Sagrada Familia in Buenos Aires, Argentina BOSTON, July 30, 2025 /PRNewswire/ -- CereVasc, Inc.
8h
TipRanks on MSNAbbVie’s Promising Study on Mirvetuximab Soravtansine for Platinum-Resistant CancersAbbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is currently conducting a study titled A ...
(Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the first patient has been dosed in the pivotal Phase 3 OVATION 3 Study ...
14h
Your Horse on MSNPeritonitis in horses explainedProblems with the horse’s stomach can sometimes be attributed to peritonitis, which is a very serious illness that can lead to large claims on any horse health insurance policy. Peritonitis refers to ...
Supreme Court of New York, Appellate Division, Fourth Department - In this personal injury action, plaintiff Joseph Skrzynski alleged ...
A woman who struggled to recover from a bout of food poisoning after her Christmas work do went on to be diagnosed with a ...
HIPEC is an often-overlooked form of chemotherapy, with a long track record. It's improving survival rates in some abdominal ...
World Hepatitis Day is the global campaign organized annually on July 28 by the World Health Organization (WHO) to increase ...
A 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated using Cytoreductive Surgery ...
AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...
In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with ...
Mesothelioma is a particular form of cancer, often spurred by asbestos exposure. It's rare. It's deadly and known to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results